JoVE Logo

로그인

Clearance is a key pharmacokinetic parameter that quantifies the volume of body fluid from which a drug is entirely removed within a specific time frame. It is crucial in assessing how a drug is eliminated from the body and has critical clinical applications.

In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent volume of distribution to estimate clearance. Total body clearance is the cumulative clearance by all eliminating organs, whereas total systemic clearance is the aggregate of individual organ clearances, illustrating how the body processes the drug.

Hepatic clearance, which evaluates drug elimination by the liver is estimated by dividing the elimination rate by the drug concentration presented to the liver. It can be further categorized into hepatic blood flow rate-limited clearance and intrinsic capacity-limited clearance. Drug clearance in the kidneys and other organs can be estimated similarly by dividing the elimination rate by the drug concentration presented to the kidneys and other organs respectively.

Several methods, including the method of residuals, can be used to calculate clearance. This technique separates a multiexponential curve into its components. By analyzing plasma concentration-time profiles and applying suitable equations, we can estimate clearance to understand drug elimination from the body.

Tags

ClearancePharmacokineticsIV Bolus AdministrationElimination RatePlasma Drug ConcentrationTotal Body ClearanceSystemic ClearanceHepatic ClearanceDrug EliminationKidney ClearanceMethod Of ResidualsPlasma Concentration time Profiles

장에서 7:

article

Now Playing

7.5 : One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance

Pharmacokinetic Models

45 Views

article

7.1 : Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

Pharmacokinetic Models

55 Views

article

7.2 : Model Approaches for Pharmacokinetic Data: Compartment Models

Pharmacokinetic Models

53 Views

article

7.3 : One-Compartment Open Model for IV Bolus Administration: General Considerations

Pharmacokinetic Models

114 Views

article

7.4 : One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution

Pharmacokinetic Models

115 Views

article

7.6 : One-Compartment Model: IV Infusion

Pharmacokinetic Models

117 Views

article

7.7 : One-Compartment Open Model for Extravascular Administration: Zero-Order Absorption Model

Pharmacokinetic Models

41 Views

article

7.8 : One-Compartment Open Model for Extravascular Administration: First-Order Absorption Model

Pharmacokinetic Models

163 Views

article

7.9 : One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

Pharmacokinetic Models

225 Views

article

7.10 : One-Compartment Open Model: Urinary Excretion Data and Determination of k

Pharmacokinetic Models

79 Views

article

7.11 : Multicompartment Models: Overview

Pharmacokinetic Models

61 Views

article

7.12 : Two-Compartment Open Model: Overview

Pharmacokinetic Models

77 Views

article

7.13 : Two-Compartment Open Model: IV Bolus Administration

Pharmacokinetic Models

234 Views

article

7.14 : Two-Compartment Open Model: IV Infusion

Pharmacokinetic Models

157 Views

article

7.15 : Two-Compartment Open Model: Extravascular Administration

Pharmacokinetic Models

113 Views

See More

JoVE Logo

개인 정보 보호

이용 약관

정책

연구

교육

JoVE 소개

Copyright © 2025 MyJoVE Corporation. 판권 소유